TG THERAPEUTICS, INC. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Tg Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2023.
  • Tg Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $418M, a 4.48% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $418M +$18M +4.48% Dec 31, 2023 10-K 2024-02-29
Q4 2022 $400M +$32.9M +8.96% Dec 31, 2022 10-K 2024-02-29
Q4 2021 $367M +$90.7M +32.8% Dec 31, 2021 10-K 2023-03-01
Q4 2020 $277M +$90M +48.2% Dec 31, 2020 10-K 2022-03-01
Q4 2019 $187M +$43.8M +30.6% Dec 31, 2019 10-K 2021-03-01
Q4 2018 $143M +$43.2M +43.4% Dec 31, 2018 10-K 2020-03-02
Q4 2017 $99.7M -$16.5M -14.2% Dec 31, 2017 10-K 2019-03-01
Q4 2016 $116M +$29.8M +34.5% Dec 31, 2016 10-K 2018-03-15
Q4 2015 $86.4M +$17.3M +25% Dec 31, 2015 10-K 2018-03-15
Q4 2014 $69.1M +$22.8M +49.3% Dec 31, 2014 10-K 2016-03-15
Q4 2013 $46.3M +$10M +27.6% Dec 31, 2013 10-K 2016-03-15
Q4 2012 $36.3M +$6.86M +23.3% Dec 31, 2012 10-K 2014-03-07
Q4 2011 $29.4M Dec 31, 2011 10-K 2013-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.